Reviews Voriconazole


No reviews yet.

Vfend Drug Description
VFEND® I.V.
(voriconazole) for Injection
VFEND® Tablets
(voriconazole)
VFEND®
(voriconazole) for Oral Suspension
DRUG DESCRIPTION



What are the possible side effects of voriconazole (VFEND)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

sudden behavior changes, problems with thinking or speech;
stomach pain, loss of appetite, dark urine, jaundice (yellowing of the skin or eyes);
urinating less than usual or not at all;
fever, sore throat, and headache with a...
Read All Potential Side Effects for Vfend »




VFEND® (voriconazole), a triazole antifungal agent, is available as a lyophilized
powder for solution for intravenous infusion, film-coated tablets for oral administration,
and as a powder for oral suspension. The structural formula is:








Voriconazole is designated chemically as (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol
with an empirical formula of C16H14F3N5O
and a molecular weight of 349.3.
Voriconazole drug substance is a white to light-colored powder.
VFEND I.V. is a white lyophilized powder containing nominally 200 mg voriconazole and 3200 mg sulfobutyl ether beta-cyclodextrin sodium in a 30 mL Type I clear glass vial.
VFEND I.V. is intended for administration by intravenous infusion. It is a
single-dose, unpreserved product. Vials containing 200 mg lyophilized voriconazole
are intended for reconstitution with Water for Injection to produce a solution
containing 10 mg/mL VFEND and 160 mg/mL of sulfobutyl ether beta-cyclodextrin
sodium. The resultant solution is further diluted prior to administration as
an intravenous infusion (see DOSAGE AND ADMINISTRATION).
VFEND Tablets contain 50 mg or 200 mg of voriconazole. The inactive ingredients
include lactose monohydrate, pregelatinized starch, croscarmellose sodium, povidone,
magnesium stearate and a coating containing hypromellose, titanium dioxide,
lactose monohydrate and triacetin.
VFEND for Oral Suspension is a white to off-white powder providing a white to off-white orange-flavored suspension when reconstituted. Bottles containing 45 g powder for oral suspension are intended for reconstitution with water to produce a suspension containing 40 mg/mL voriconazole. The inactive ingredients include colloidal silicon dioxide, titanium dioxide, xanthan gum, sodium citrate dihydrate, sodium benzoate, anhydrous citric acid, natural orange flavor, and sucrose.Last reviewed on RxList: 7/12/2010




Vfend Drug Description
VFEND® I.V.
(voriconazole) for Injection
VFEND® Tablets
(voriconazole)
VFEND®
(voriconazole) for Oral Suspension
DRUG DESCRIPTION



What are the possible side effects of voriconazole (VFEND)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

sudden behavior changes, problems with thinking or speech;
stomach pain, loss of appetite, dark urine, jaundice (yellowing of the skin or eyes);
urinating less than usual or not at all;
fever, sore throat, and headache with a...
Read All Potential Side Effects for Vfend »




VFEND® (voriconazole), a triazole antifungal agent, is available as a lyophilized
powder for solution for intravenous infusion, film-coated tablets for oral administration,
and as a powder for oral suspension. The structural formula is:








Voriconazole is designated chemically as (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol
with an empirical formula of C16H14F3N5O
and a molecular weight of 349.3.
Voriconazole drug substance is a white to light-colored powder.
VFEND I.V. is a white lyophilized powder containing nominally 200 mg voriconazole and 3200 mg sulfobutyl ether beta-cyclodextrin sodium in a 30 mL Type I clear glass vial.
VFEND I.V. is intended for administration by intravenous infusion. It is a
single-dose, unpreserved product. Vials containing 200 mg lyophilized voriconazole
are intended for reconstitution with Water for Injection to produce a solution
containing 10 mg/mL VFEND and 160 mg/mL of sulfobutyl ether beta-cyclodextrin
sodium. The resultant solution is further diluted prior to administration as
an intravenous infusion (see DOSAGE AND ADMINISTRATION).
VFEND Tablets contain 50 mg or 200 mg of voriconazole. The inactive ingredients
include lactose monohydrate, pregelatinized starch, croscarmellose sodium, povidone,
magnesium stearate and a coating containing hypromellose, titanium dioxide,
lactose monohydrate and triacetin.
VFEND for Oral Suspension is a white to off-white powder providing a white to off-white orange-flavored suspension when reconstituted. Bottles containing 45 g powder for oral suspension are intended for reconstitution with water to produce a suspension containing 40 mg/mL voriconazole. The inactive ingredients include colloidal silicon dioxide, titanium dioxide, xanthan gum, sodium citrate dihydrate, sodium benzoate, anhydrous citric acid, natural orange flavor, and sucrose.Last reviewed on RxList: 7/12/2010




Vfend Drug Description
VFEND® I.V.
(voriconazole) for Injection
VFEND® Tablets
(voriconazole)
VFEND®
(voriconazole) for Oral Suspension
DRUG DESCRIPTION



What are the possible side effects of voriconazole (VFEND)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

sudden behavior changes, problems with thinking or speech;
stomach pain, loss of appetite, dark urine, jaundice (yellowing of the skin or eyes);
urinating less than usual or not at all;
fever, sore throat, and headache with a...
Read All Potential Side Effects for Vfend »




VFEND® (voriconazole), a triazole antifungal agent, is available as a lyophilized
powder for solution for intravenous infusion, film-coated tablets for oral administration,
and as a powder for oral suspension. The structural formula is:








Voriconazole is designated chemically as (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol
with an empirical formula of C16H14F3N5O
and a molecular weight of 349.3.
Voriconazole drug substance is a white to light-colored powder.
VFEND I.V. is a white lyophilized powder containing nominally 200 mg voriconazole and 3200 mg sulfobutyl ether beta-cyclodextrin sodium in a 30 mL Type I clear glass vial.
VFEND I.V. is intended for administration by intravenous infusion. It is a
single-dose, unpreserved product. Vials containing 200 mg lyophilized voriconazole
are intended for reconstitution with Water for Injection to produce a solution
containing 10 mg/mL VFEND and 160 mg/mL of sulfobutyl ether beta-cyclodextrin
sodium. The resultant solution is further diluted prior to administration as
an intravenous infusion (see DOSAGE AND ADMINISTRATION).
VFEND Tablets contain 50 mg or 200 mg of voriconazole. The inactive ingredients
include lactose monohydrate, pregelatinized starch, croscarmellose sodium, povidone,
magnesium stearate and a coating containing hypromellose, titanium dioxide,
lactose monohydrate and triacetin.
VFEND for Oral Suspension is a white to off-white powder providing a white to off-white orange-flavored suspension when reconstituted. Bottles containing 45 g powder for oral suspension are intended for reconstitution with water to produce a suspension containing 40 mg/mL voriconazole. The inactive ingredients include colloidal silicon dioxide, titanium dioxide, xanthan gum, sodium citrate dihydrate, sodium benzoate, anhydrous citric acid, natural orange flavor, and sucrose.Last reviewed on RxList: 7/12/2010




Vfend Drug Description
VFEND® I.V.
(voriconazole) for Injection
VFEND® Tablets
(voriconazole)
VFEND®
(voriconazole) for Oral Suspension
DRUG DESCRIPTION



What are the possible side effects of voriconazole (VFEND)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

sudden behavior changes, problems with thinking or speech;
stomach pain, loss of appetite, dark urine, jaundice (yellowing of the skin or eyes);
urinating less than usual or not at all;
fever, sore throat, and headache with a...
Read All Potential Side Effects for Vfend »




VFEND® (voriconazole), a triazole antifungal agent, is available as a lyophilized
powder for solution for intravenous infusion, film-coated tablets for oral administration,
and as a powder for oral suspension. The structural formula is:








Voriconazole is designated chemically as (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol
with an empirical formula of C16H14F3N5O
and a molecular weight of 349.3.
Voriconazole drug substance is a white to light-colored powder.
VFEND I.V. is a white lyophilized powder containing nominally 200 mg voriconazole and 3200 mg sulfobutyl ether beta-cyclodextrin sodium in a 30 mL Type I clear glass vial.
VFEND I.V. is intended for administration by intravenous infusion. It is a
single-dose, unpreserved product. Vials containing 200 mg lyophilized voriconazole
are intended for reconstitution with Water for Injection to produce a solution
containing 10 mg/mL VFEND and 160 mg/mL of sulfobutyl ether beta-cyclodextrin
sodium. The resultant solution is further diluted prior to administration as
an intravenous infusion (see DOSAGE AND ADMINISTRATION).
VFEND Tablets contain 50 mg or 200 mg of voriconazole. The inactive ingredients
include lactose monohydrate, pregelatinized starch, croscarmellose sodium, povidone,
magnesium stearate and a coating containing hypromellose, titanium dioxide,
lactose monohydrate and triacetin.
VFEND for Oral Suspension is a white to off-white powder providing a white to off-white orange-flavored suspension when reconstituted. Bottles containing 45 g powder for oral suspension are intended for reconstitution with water to produce a suspension containing 40 mg/mL voriconazole. The inactive ingredients include colloidal silicon dioxide, titanium dioxide, xanthan gum, sodium citrate dihydrate, sodium benzoate, anhydrous citric acid, natural orange flavor, and sucrose.Last reviewed on RxList: 7/12/2010




Vfend Drug Description
VFEND® I.V.
(voriconazole) for Injection
VFEND® Tablets
(voriconazole)
VFEND®
(voriconazole) for Oral Suspension
DRUG DESCRIPTION



What are the possible side effects of voriconazole (VFEND)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

sudden behavior changes, problems with thinking or speech;
stomach pain, loss of appetite, dark urine, jaundice (yellowing of the skin or eyes);
urinating less than usual or not at all;
fever, sore throat, and headache with a...
Read All Potential Side Effects for Vfend »




VFEND® (voriconazole), a triazole antifungal agent, is available as a lyophilized
powder for solution for intravenous infusion, film-coated tablets for oral administration,
and as a powder for oral suspension. The structural formula is:








Voriconazole is designated chemically as (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol
with an empirical formula of C16H14F3N5O
and a molecular weight of 349.3.
Voriconazole drug substance is a white to light-colored powder.
VFEND I.V. is a white lyophilized powder containing nominally 200 mg voriconazole and 3200 mg sulfobutyl ether beta-cyclodextrin sodium in a 30 mL Type I clear glass vial.
VFEND I.V. is intended for administration by intravenous infusion. It is a
single-dose, unpreserved product. Vials containing 200 mg lyophilized voriconazole
are intended for reconstitution with Water for Injection to produce a solution
containing 10 mg/mL VFEND and 160 mg/mL of sulfobutyl ether beta-cyclodextrin
sodium. The resultant solution is further diluted prior to administration as
an intravenous infusion (see DOSAGE AND ADMINISTRATION).
VFEND Tablets contain 50 mg or 200 mg of voriconazole. The inactive ingredients
include lactose monohydrate, pregelatinized starch, croscarmellose sodium, povidone,
magnesium stearate and a coating containing hypromellose, titanium dioxide,
lactose monohydrate and triacetin.
VFEND for Oral Suspension is a white to off-white powder providing a white to off-white orange-flavored suspension when reconstituted. Bottles containing 45 g powder for oral suspension are intended for reconstitution with water to produce a suspension containing 40 mg/mL voriconazole. The inactive ingredients include colloidal silicon dioxide, titanium dioxide, xanthan gum, sodium citrate dihydrate, sodium benzoate, anhydrous citric acid, natural orange flavor, and sucrose.Last reviewed on RxList: 7/12/2010





Other reviews about Voriconazole on wordpress

Topical Voriconazole as a Novel Treatment for Fungal Keratitis
  by JOC
Source: Antimicrobial Agents and Chemotherapy Jan 2006 p.262-268 Vol.50 No.1 William Sponsel,1 Nancy Chen,1 Demi Dang,1 Gianmarco Paris,1 John Graybill,1 Laura K. Najvar,1* Lei Zhou,2 Kwok-Wai Lam,2 Randolph Glickman,1 […]


Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia
  by olennikov2
Pharmacotherapy 28(1): 58-63 Abstract Study Objective. To determine the success rate and toxicity profile of oral voriconazole when used as empiric antifungal therapy in patients with uncomplicated […]


Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia
  by pushkinblog
Pharmacotherapy 28(1): 58-63 Abstract Study Objective. To determine the success rate and toxicity profile of oral voriconazole when used as empiric antifungal therapy in patients with uncomplicated […]


Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia
  by gipson28
Pharmacotherapy 28(1): 58-63 Abstract Study Objective. To determine the success rate and toxicity profile of oral voriconazole when used as empiric antifungal therapy in patients with uncomplicated […]


Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia
  by bizon28
Pharmacotherapy 28(1): 58-63 Abstract Study Objective. To determine the success rate and toxicity profile of oral voriconazole when used as empiric antifungal therapy in patients with uncomplicated […]


Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia
  by brucelee2
Pharmacotherapy 28(1): 58-63 Abstract Study Objective. To determine the success rate and toxicity profile of oral voriconazole when used as empiric antifungal therapy in patients with uncomplicated […]


Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia
  by paxilpharm
Pharmacotherapy 28(1): 58-63 Abstract Study Objective. To determine the success rate and toxicity profile of oral voriconazole when used as empiric antifungal therapy in patients with uncomplicated […]


Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia
  by phentermine38
Pharmacotherapy 28(1): 58-63 Abstract Study Objective. To determine the success rate and toxicity profile of oral voriconazole when used as empiric antifungal therapy in patients with uncomplicated […]


Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia
  by jeison298
Pharmacotherapy 28(1): 58-63 Abstract Study Objective. To determine the success rate and toxicity profile of oral voriconazole when used as empiric antifungal therapy in patients with uncomplicated […]


Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
  by JOC
N Engl J Medicine  8 August 2002  V.347 N.6  p.408-15 Raoul Herbrecht, M.D., David W. Denning, F.R.C.P., Thomas F. Patterson, M.D., John E. Bennett, M.D., Reginald E. Greene, M.D., […]



Other reviews about Voriconazole on web:

Voriconazole (VFEND, Pfizer) is a triazole antifungal medication that is generally used to treat serious, invasive fungal infections. These are generally seen in patients who ... Voriconazole - Wikipedia, the free encyclopedia


Voriconazole is used to treat serious fungal infections such as invasive aspergillosis (a fungal infection that begins in the lungs and spreads through the bloodstream to other ... Voriconazole: MedlinePlus Drug Information


Voriconazole Brand names: VFEND® Chemical formula: Drug Forms: Voriconazole Oral suspension (below) Voriconazole Oral tablet Voriconazole Voriconazole: Definition from Answers.com


Learn about the prescription medication Vfend (Voriconazole), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Vfend (Voriconazole) Drug Information: Uses, Side Effects, Drug ...


Voriconazole is active following oral and intravenous administrations; Voriconazole is in late Phase III clinical trials. Voriconazole


All about Voriconazole. View complete and up to date Voriconazole information - part of the Drugs.com trusted medication database. Voriconazole Facts and Comparisons at Drugs.com


Consumer information about the medication VORICONAZOLE - ORAL (Vfend), includes side effects, drug interactions, recommended dosages, and storage information. Read more about the ... VORICONAZOLE - ORAL (Vfend) side effects, medical uses, and drug ...


Neither DoctorFungus Corporation nor its editorial staff can be held responsible for errors or for any consequences arising from the use of the information in this website. Legal Stuff


voriconazole, an antifungal agent used to treat invasive aspergillosis and serious fungal infections. voriconazole. a fluconazole derivative with potent activity against fungal ... voriconazole - definition of voriconazole in the Medical ...


Learn more about Voriconazole. Find the Web's best health guides, medical reports, news, videos and tools for Voriconazole. Share Voriconazole experiences and get advice from ... Voriconazole Overview - References, Advice, News, Videos, Coping ...





Featured Reviews

Reviews Thiopental Sodium

Pentothal Drug Description Pentothal (thiopental sodium) for Injection, USP DRUG DESCRIPTION What are the possible side effects of thiopental (Pentothal)? You will remain under constant supervision during treatment with thiopental....
Read More  |  Review This
Reviews Skelaxin

Skelaxin Drug Description SKELAXIN® (metaxalone) Tablets DRUG DESCRIPTION What are the possible side effects of metaxalone (Skelaxin)? Get emergency medical help if you have any of these signs of an allergic reaction: hives;...
Read More  |  Review This
Reviews Maraviroc

Selzentry Drug Description SELZENTRY (maraviroc) Tablets WARNING HEPATOTOXICITY Hepatotoxicity has been reported with SELZENTRY use. Evidence of a systemic allergic reaction (e.g., pruritic rash, eosinophilia or elevated IgE)...
Read More  |  Review This
Reviews Cortenema

Cortenema Drug Description CORTENEMA® (hydrocortisone retention enema) 100mg/60mL DISPOSABLE UNIT FOR RECTAL USE ONLY DRUG DESCRIPTION What are the possible side effects of hydrocortisone rectal foam or enema (Colocort, Cortenema,...
Read More  |  Review This
Reviews Diphenhydramine Injection

Benadryl Injection Drug Description Benadryl® (diphenhydramine hydrochloride) Injection, USP DRUG DESCRIPTION Benadryl (diphenhydramine hydrochloride) is an antihistamine drug having the chemical name 2-(Diphenylmethoxy)-N,N-dimethylethylamine...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....